DGL 감초 (속쓰림)

Difference in the risk of gastrointestinal manifestations between peritoneal and hemodialysis patients: a systematic review and meta-analysis.

1. PeerJ. 2026 Apr 14;14:e21090. doi: 10.7717/peerj.21090. eCollection 2026. Difference in the risk of gastrointestinal manifestations between peritoneal and hemodialysis patients: a systematic review and meta-analysis. Li J(1), Liang J(2), Shi X(2), Lu W(3). Author information: (1)Nephrology De

Efficacy and safety of probiotics combined with bismuth-containing quadruple therapy for Helicobacter pylori eradication: a systematic review and meta-analysis.

2. Front Microbiol. 2026 Jan 7;16:1704508. doi: 10.3389/fmicb.2025.1704508. eCollection 2025. Efficacy and safety of probiotics combined with bismuth-containing quadruple therapy for Helicobacter pylori eradication: a systematic review and meta-analysis. Zhou S(#)(1)(2), Yu Y(#)(2), Tian J(1)(2

A systematic review and meta-analysis of randomized controlled trials: the effect of potassium-competitive acid blockers on nighttime symptoms of gastroesophageal reflux disease.

3. Esophagus. 2026 Apr;23(2):275-291. doi: 10.1007/s10388-025-01181-0. Epub 2026 Jan 12. A systematic review and meta-analysis of randomized controlled trials: the effect of potassium-competitive acid blockers on nighttime symptoms of gastroesophageal reflux disease. Koo TH(1)(2)(3), Fass R(4).

Efficacy, safety and cost-effectiveness of potassium-competitive acid blockers versus proton pump inhibitors in gastroesophageal reflux disease.

4. Scand J Gastroenterol. 2026 Feb;61(2):241-256. doi: 10.1080/00365521.2025.2603613. Epub 2025 Dec 23. Efficacy, safety and cost-effectiveness of potassium-competitive acid blockers versus proton pump inhibitors in gastroesophageal reflux disease. Li F(1), Tan J(1), Qin L(1). Author informatio

Long-term (>10 Years) Outcomes of Laparoscopic Nissen Fundoplication: A Systematic Review and Meta-Analysis.

5. Ann Surg. 2026 Apr 1;283(4):539-545. doi: 10.1097/SLA.0000000000007000. Epub 2025 Dec 18. Long-term (>10 Years) Outcomes of Laparoscopic Nissen Fundoplication: A Systematic Review and Meta-Analysis. Principe J(1), Angeramo CA(1), Barros Sosa J(1), Baz Gallego JJ(1), Herbella FAM(2), Patti MG

Global prevalence and risk of gastroesophageal reflux disease symptoms in pregnancy: a systematic review and meta-analysis.

6. BMC Pregnancy Childbirth. 2025 Dec 9;26(1):44. doi: 10.1186/s12884-025-08569-x. Global prevalence and risk of gastroesophageal reflux disease symptoms in pregnancy: a systematic review and meta-analysis. Khurmatullina AR(1), Andreev DN(2), Maev IV(3), Lyamina SV(3), Kucheryavyy YA(4), Beliy P

Durability and reflux outcomes of peroral endoscopic myotomy compared to laparoscopic heller myotomy in achalasia: a meta-analysis of long-term studies.

7. Dis Esophagus. 2025 Nov 1;38(6):doaf111. doi: 10.1093/dote/doaf111. Durability and reflux outcomes of peroral endoscopic myotomy compared to laparoscopic heller myotomy in achalasia: a meta-analysis of long-term studies. Abosheisha M(1), Nasr E(2), Kandeel M(3), Asaad A(4), Alhammali T(5), Ale

[Safety and efficacy of endoscopic and surgical anti-reflux procedures for gastroesophageal reflux disease: a systematic review and network meta-analysis].

8. Zhonghua Wei Chang Wai Ke Za Zhi. 2025 Oct 25;28(10):1161-1178. doi: 10.3760/cma.j.cn441530-20250724-00280. [Safety and efficacy of endoscopic and surgical anti-reflux procedures for gastroesophageal reflux disease: a systematic review and network meta-analysis]. [Article in Chinese; Abstract

The positive role of Chinese herbal medicine as an adjunctive therapy for refractory gastroesophageal reflux disease: A systematic review and network meta-analysis.

9. Medicine (Baltimore). 2025 May 23;104(21):e42565. doi: 10.1097/MD.0000000000042565. The positive role of Chinese herbal medicine as an adjunctive therapy for refractory gastroesophageal reflux disease: A systematic review and network meta-analysis. Zhang R(1), Yang Z(1), Pan X(1)(2), Liu Y(1

A systematic review and meta-analysis of randomized controlled trials: the role of potassium-competitive acid blockers in endoscopy-negative reflux disease.

10. Dig Liver Dis. 2025 Sep;57(9):1752-1760. doi: 10.1016/j.dld.2025.04.045. Epub 2025 May 16. A systematic review and meta-analysis of randomized controlled trials: the role of potassium-competitive acid blockers in endoscopy-negative reflux disease. Koo TH(1), Fass R(2). Author information: (

Wedge Pillow Versus Evening Proton Pump Inhibitor for Nocturnal Reflux Symptoms: A Noninferiority Randomized Trial.

11. Neurogastroenterol Motil. 2026 Feb;38(2):e70256. doi: 10.1111/nmo.70256. Wedge Pillow Versus Evening Proton Pump Inhibitor for Nocturnal Reflux Symptoms: A Noninferiority Randomized Trial. Hirunrattanaporn K(1), Prueksapanich P(1), Gonlachanvit S(1)(2), Patcharatrakul T(1)(2). Author inform

Acupuncture provides a safe strategy to minimize proton pump inhibitor dose in resistant gastroesophageal reflux disease: randomized controlled trial.

12. Dis Esophagus. 2026 Jan 9;39(1):doag001. doi: 10.1093/dote/doag001. Acupuncture provides a safe strategy to minimize proton pump inhibitor dose in resistant gastroesophageal reflux disease: randomized controlled trial. Ghadiani Z(1), Gorjizadeh N(1), Azadvari M(2), Sharifi A(1), Jamali R(1).

Role of antireflux mucosal ablation in "reflux-predominant" refractory gastroesophageal reflux disease: a randomized sham-controlled trial.

13. Endoscopy. 2026 May;58(5):456-464. doi: 10.1055/a-2740-9297. Epub 2025 Nov 6. Role of antireflux mucosal ablation in "reflux-predominant" refractory gastroesophageal reflux disease: a randomized sham-controlled trial. Chavan D(1), Koduri KK(1), Singh AP(1), Maragoni RG(1), Jagtap N(1), Kalapa

A randomized, three-way crossover clinical trial on the efficacy of Mastiha based therapies (Pistacia lentiscus var. Chia) in functional dyspepsia.

14. Pharmacol Res. 2025 Dec;222:108019. doi: 10.1016/j.phrs.2025.108019. Epub 2025 Nov 4. A randomized, three-way crossover clinical trial on the efficacy of Mastiha based therapies (Pistacia lentiscus var. Chia) in functional dyspepsia. Kleftaki SA(1), Amerikanou C(2), Tzavara C(1), Biagki T(1)

Uncovering the Mechanisms of Failure of Proton Pump Inhibitors in GERD: The Role of Esophageal Acid Sensitivity.

15. Dig Dis Sci. 2026 Mar;71(3):1041-1048. doi: 10.1007/s10620-025-09450-9. Epub 2025 Sep 30. Uncovering the Mechanisms of Failure of Proton Pump Inhibitors in GERD: The Role of Esophageal Acid Sensitivity. Gardner JD(1)(2), Triadafilopoulos G(3)(4). Author information: (1)Science for Organizat

Comparable efficacy of generic and original alginate for symptom control in PPI-refractory GERD.

36. Sci Rep. 2025 Aug 4;15(1):28429. doi: 10.1038/s41598-025-13400-w. Comparable efficacy of generic and original alginate for symptom control in PPI-refractory GERD. Tangvoraphonkchai K(1), Manasirisuk W(2), Apichatvullop T(3), Srikhajonjit S(3), Mitpracha M(3), Promsen P(4), Preechakawin N(5),

Exploratory analyses of meal-induced heartburn identify distinct clinical phenotypes of gastroesophageal reflux disease.

31. Physiol Rep. 2025 Jul;13(14):e70469. doi: 10.14814/phy2.70469. Exploratory analyses of meal-induced heartburn identify distinct clinical phenotypes of gastroesophageal reflux disease. Gardner JD(1)(2), Triadafilopoulos G(2)(3). Author information: (1)Science for Organizations, Mill Valley, C

Zatariamultiflora hydroalcoholic extract: A triple-blind randomized controlled trial on immune genes, inflammation, and ulcerative colitis symptoms.

46. J Ethnopharmacol. 2025 Mar 26;344:119527. doi: 10.1016/j.jep.2025.119527. Epub 2025 Feb 21. Zatariamultiflora hydroalcoholic extract: A triple-blind randomized controlled trial on immune genes, inflammation, and ulcerative colitis symptoms. Morvaridi M(1), Aryaeian N(2), Alavinejad P(3), Sey

Efficacy and Safety of GutGard® in Managing Gastroesophageal Reflux-Related Symptoms: A Phase III, Single-Centre, Double-Blind, Randomized Placebo-Controlled Trial.

40. Complement Med Res. 2025;32(1):26-36. doi: 10.1159/000543367. Epub 2025 Feb 10. Efficacy and Safety of GutGard® in Managing Gastroesophageal Reflux-Related Symptoms: A Phase III, Single-Centre, Double-Blind, Randomized Placebo-Controlled Trial. Raj JP(1)(2), Saxena U(2), Belhekar MN(2), Mamd

Iodine Staining With Distance Countdown Improving the Safety for Reduction of Adverse Events: A Randomized Controlled Trial.

7. Clin Transl Gastroenterol. 2025 Mar 1;16(3):e00822. doi: 10.14309/ctg.0000000000000822. Iodine Staining With Distance Countdown Improving the Safety for Reduction of Adverse Events: A Randomized Controlled Trial. Xi M(1)(2), Luo X(3), Chen F(1)(2), Wang Z(1)(2), Xiao X(1)(2), Luo B(1)(2), Ch

Helichrysum odoratissimum (L.) Less: A Review of Its Volatile and Non-Volatile Compounds, Ethnomedicine, Pharmacological Properties and Evidence on Safety Trials in Humans.

36. Plants (Basel). 2026 Apr 21;15(8):1275. doi: 10.3390/plants15081275. Helichrysum odoratissimum (L.) Less: A Review of Its Volatile and Non-Volatile Compounds, Ethnomedicine, Pharmacological Properties and Evidence on Safety Trials in Humans. Ramadwa TE(1), Meddows-Taylor S(1). Author inform

Dual Primary Gastric and Rectal Adenocarcinoma: A Case Report with Management Insights : Dual Primary Gastric and Rectal Adenocarcinoma.

23. Galen Med J. 2025 Jul 7;14:e3742. doi: 10.31661/gmj.v14i.3742. eCollection 2025. Dual Primary Gastric and Rectal Adenocarcinoma: A Case Report with Management Insights : Dual Primary Gastric and Rectal Adenocarcinoma. Dastjerdi A(1), Samami E(2), Javadinia SA(3), Anvary M(4), Kazemzadeh A(5),

Functional Esophageal Disorders.

4. Gastroenterology. 2026 May;170(6):1224-1239. doi: 10.1053/j.gastro.2026.02.005. Epub 2026 Feb 18. Functional Esophageal Disorders. Gyawali CP(1), Roman S(2), Zerbib F(3), Savarino EV(4), Bhatia S(5), Fass R(6), Pandolfino JE(7). Author information: (1)Division of Gastroenterology, Washington

Tegoprazan in Gastroesophageal Reflux Disease and Related Acid-Mediated Conditions: A Systematic Review and Meta-Analysis.

45. JGH Open. 2026 Apr 17;10(4):e70406. doi: 10.1002/jgh3.70406. eCollection 2026 Apr. Tegoprazan in Gastroesophageal Reflux Disease and Related Acid-Mediated Conditions: A Systematic Review and Meta-Analysis. Bandyopadhyay S(1), Goenka M(2), Routh D(3), Ramesh GN(4), Lawate P(5). Author inform

Effect of endoscopic pre-aponeurotic repair of diastasis recti on gastroesophageal reflux symptoms: An observational retrospective study.

31. Indian J Gastroenterol. 2026 Apr 16. doi: 10.1007/s12664-026-01995-5. Online ahead of print. Effect of endoscopic pre-aponeurotic repair of diastasis recti on gastroesophageal reflux symptoms: An observational retrospective study. Cuccomarino S(1), Toscano A(2), Palmisano EM(3), Juárez Muas

Real-World Effectiveness and Safety of Saccharomyces boulardii CNCM I-745 as Adjunct Therapy for Helicobacter pylori Eradication: Data From the European Registry on H. pylori Management (Hp-EuReg).

16. Helicobacter. 2026 Mar-Apr;31(2):e70119. doi: 10.1111/hel.70119. Real-World Effectiveness and Safety of Saccharomyces boulardii CNCM I-745 as Adjunct Therapy for Helicobacter pylori Eradication: Data From the European Registry on H. pylori Management (Hp-EuReg). Nyssen OP(1), Jonaitis L(2),

Systemic bismuth absorption and safety of the gastric mucosal protective bismuth potassium citrate, administered as granules and tablets in healthy Chinese and validation of a new, ICP-MS bismuth assay.

42. Int J Clin Pharmacol Ther. 2026 Mar 25. doi: 10.5414/CP204626. Online ahead of print. Systemic bismuth absorption and safety of the gastric mucosal protective bismuth potassium citrate, administered as granules and tablets in healthy Chinese and validation of a new, ICP-MS bismuth assay. Lv

Self-management of reflux-like symptoms: A patient-centered decision-making approach.

49. Dig Dis. 2026 Mar 24:1-22. doi: 10.1159/000551414. Online ahead of print. Self-management of reflux-like symptoms: A patient-centered decision-making approach. Hungin APS, Scarpignato C, Bredenoord AJ, Fox MR, López-Pintor E, Mendive JM, Savarino EV, Kahrilas PJ. BACKGROUND: Guidelines for

Managing reflux after tubular gastric esophageal substitution.

29. World J Gastrointest Surg. 2026 Feb 27;18(2):116235. doi: 10.4240/wjgs.v18.i2.116235. Managing reflux after tubular gastric esophageal substitution. Yan LJ(1), Shen SW(1), Fang TT(2). Author information: (1)Department of Thoracic Surgery, Affiliated Hospital of Jiangnan University, Wuxi 214

Dietary Prebiotics Modulate Omeprazole-Induced Alterations in the Gut Microbial Signature.

20. Mol Nutr Food Res. 2025 Dec;69(24):e70307. doi: 10.1002/mnfr.70307. Epub 2025 Oct 30. Dietary Prebiotics Modulate Omeprazole-Induced Alterations in the Gut Microbial Signature. Buccola MJ(1), Satheesh Babu AK(1), Paz HA(2)(3), Porter ND(1), Srinivasan H(1), Ricks RL(1), Rosquist K(1), Torre